Numaferm
Biotechnology
$2Mraised in 5 rounds
1backers · High-Tech Gründerfonds
$2Mgrants · 5 grants · CORDIS
11stories in the press
Overview
Numaferm believes in peptides, pepteins & proteins as feedstock for better, safer & healthier products in life sciences & beyond.
Funding and backers
Grants
$2M
5 grants · CORDIS
Backers
1
High-Tech Gründerfonds
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 1, 2023
Won a grant $187k · CORDIS
Feb 1, 2022
Won a grant $697k · CORDIS
Apr 1, 2019
Won a grant $871k · CORDIS
Nov 1, 2018
Won a grant $54k · CORDIS
May 1, 2017
Won a grant $194k · CORDIS
2017
Founded
Funding rounds
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Space cargo return service for life sciences. Overcoming challenges in life sciences research in space. Affordable, reliable…
Immunoassays for any Protein, any Specimen and any Species. SIGNATOPE offers next generation quantitative assays for your protein biomarker…
O2h technology. Seeding new ideas in life science, tech and green innovation.
Aventior builds GenAI and Agentic AI platforms that automate workflows, structure enterprise data, and accelerate critical decisions in…
Decoding the human protein interactome for safer, more targeted therapies.. 95% of approved medicines target proteins as isolated entities…
Cyclize's technology turns hard-to-recycle plastic waste and CO₂ into high-quality syngas, replacing fossil feedstocks in the chemical…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
High-Tech GründerfondsVia a fund
517 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
BIO International Convention 2026
Our CSO and Co-Founder Christian Schwarz and Our CEO Roland Hecht will be attending BIO International Convention USA from June 22-25, 2026. Get in touch with us via the Partnering Portal or drop by booth 3317-F at the German Pavilion for a quick chat. The
Read more
Report
bio:cap Life Science and AI Investival
Our CSO Christian Schwarz will be attending bio:cap from June 9-11 at Berlin. Get in touch with him via LinkedIn or the Partnering Portal to arrange for meetings The post bio:cap Life Science and AI Investival appeared first on Numaferm.
Read more
Report
PEGS Boston 2026
Our CSO, Dr. Christian Schwarz is currently attending PEGS Boston from 11-15 May, 2026. Anyone interested in arranging meetings can write to [email protected] or reach him directly via DM on LinkedIn. The post PEGS Boston 2026 appeared first on Numaferm.
Read more
Report
HTGF Family Days 2026
Our CEO, Dr. Roland Hecht attended the HTGF Family Days in Berlin from 11-12 May, 2026. The post HTGF Family Days 2026 appeared first on Numaferm.
Read more
Report
Swiss Biotech Day 2026
Our Business Development Manager, Dr. Jitin Bali will be attending Swiss Biotech Days in Basel, Switzerland on May 4-5. We will be keen to learn more about exploring new possibilities on how we can work together. The post Swiss Biotech Day 2026 appeared f
Read more
Report
German Biotech Days 2026
Our CEO Dr Roland Hecht will be attending German Biotechnology Days in Leipzig,Germany on April 21 and 22. We will look forward to discussing exciting new opportunities to collaborate in peptein manufacturing. The post German Biotech Days 2026 appeared fi
Read more
Report
Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides
Numaferm, a Germany-based biotech company, specialized in the production of pepteins, and Zoetis, the global leading animal health company, have signed a licensing agreement for the development and production of defined veterinary therapeutics.
Read more
Report
EQS-News: Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides
Read more
Report
NUMAFERM Closes Licensing Agreement with PEPDesign
- Low cost production and superior product purity of the diabetes drug liraglutide with NUMAFERM
Read more
Report
NUMAFERM GmbH: NUMAFERM Closes Licensing Agreement with PEPDesign
- Low cost production and superior product purity of the diabetes drug liraglutide with NUMAFERM's unique technology platform - Industry seeks optimized generic drug manufacturing methods after liraglutide
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1